Return to search

The effect of sunitinib on neuroblastoma and glioblastoma cell growth

Magister Scientiae (Medical Bioscience) - MSc(MBS) / Cancer is a global health catastrophe, with neuroblastoma, the most common solid childhood tumor, and glioblastoma, a deadly brain tumor, being aggressive and unresponsive to current treatment modalities. These tumors are known to utilize uncontrollable cell proliferative capabilities as a mechanism for tumor survival. Therefore, malignant cell growth can be mitigated by targeting the essential proteins that regulate cell growth, such as receptor tyrosine kinases (RTKs). Under normal physiological conditions, RTKs bind with varying affinity to mitogenic stimuli such as growth factors such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) which, in turn, leads to receptor phosphorylation and activation.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:uwc/oai:etd.uwc.ac.za:11394/7952
Date January 2020
CreatorsRoos, Kelly
ContributorsHiss, Donavon, Flepisi, Brian
PublisherUniversity of the Western Cape
Source SetsSouth African National ETD Portal
Detected LanguageEnglish
RightsUniversity of the Western Cape

Page generated in 0.0021 seconds